You would like to read
- Dr Reddys Labs announces US launch of Sapropterin Dihydrochloride tablets
- Niti Aayog To Leverage Monitoring Mechanism Of Global Multidimensional Poverty Index
- Cipla launches Nintib to treat Idiopathic Pulmonary Fibrosis
- Cipla launches generic Nintedanib for treatment of Idiopathic Pulmonary Fibrosis
- Cadila Healthcare gains as unit acquires experimental drug from Cyprium
New Delhi [India], March 5 (ANI/NewsVoir): To call for effective dialogue and decisive action against the alarming challenges of rare diseases in India, People to People Health Foundation (PPHF), a public health organization working towards better healthcare and Niti Aayog, Co-hosted a Global Rare Disease Conference under the initiative 'Blueprint for Rare Diseases in India - Together for Rare' on the International Rare Disease Day (28 February).
The virtual conference was co-powered by Takeda Pharmaceutical and was supported by Japan Embassy.
Over 7000 rare diseases have been identified globally and experts opine that only 5 per cent of these have identified treatments. The conference witnessed engaging dialogues and discussions from eminent guests who underlined the need for increasing collaboration and commitment to tackle rare diseases out of which 450 have been reported in India affecting more than 70 million people.
Speakers in the conference stressed on the urgent need for drafting a roadmap to collect disease prevalence data and guidelines on patients' registry at the local level along with the timely release of statistics.
"Coordinated actions across key stakeholders are key to successful implementations. We can address rare disease challenges by investing more and allocating more to leave no one behind. We must change our ways and make sure that our commitments are tangible," said Dr Laxmikant Palo, CEO, PPHF.
The online event also focused on chalking out policies for evidence-based knowledge, innovation in therapies, better access to real-world data, funding of research for development for new medicines, among others. "The draft policy has proposed a high quantum of assistance for rare diseases. India has committed to provide health for all," said Rajender Kumar, Director, Prime Minister's Office, Government of India.
Speakers discussed learning from cross country models and executing tailor-made solutions that work for the nation via active involvement of all the key stakeholders simultaneously. Dr. Rakesh Sarwal, Additional Secretary, Niti Aayog said, "It is my suggestion to build a network among caregivers, healthcare providers and patients to raise awareness on rare diseases in India. Connecting them through teleconsultation or telemedicine can give access to doctors to access data on rare diseases."
The conference witnessed participation from dignitaries including Dr Laxmikant Palo (CEO, PPHF), Dr Archisman Mohapatra (Executive Director, GRID Council), Dr Rakesh Sarwal (Additional Secretary, Niti Aayog), Rajender Kumar (Director, Prime Minister's Office, Government of India), Prof Rajendra Pratap Gupta, (Chair - Dynamic Coalition on 'Internet & Jobs', Internet Governance Forum United Nations, Mumbai Metropolitan Region) and Dr Mahender Nayak (Area Senior Vice-President, ICMEA, Takeda), Susanne Weissbaecker (Head Access to Medicine, GEM, Takeda), Koki Sato General Manager, Takeda, Dr Amandeep Kang, MD NHM Chandigarh, Dr Tanushree Mondal Deputy Director of Medical Education, Govt of West Bengal, Blaine Penny, Treasurer & Co-Chair, CORD, Durhane Wong-Reiger, President & CEO, CORD, Dr Bobby John, Managing Director, Aequitas Consulting Pvt. Ltd. among others.
"Takeda is a value-driven patient-centric organization and is committed to the cause of rare diseases. We understand the challenges posed by the unmet needs in diagnosing and managing rare diseases and closely engage with multiple stakeholders at every stage of the patients' progress. Our vision is to ensure seamless access of our innovative therapies to patients and improve the standard of care through focused initiatives," said Mahendra Nayak, Area Senior Vice-President, ICMEA, Takeda, underlining the role of pharmaceutical companies in this mission.
The Global Conference on Rare Disease will bring rare diseases to the forefront of healthcare discussions to raise awareness and build partnerships for better outcomes. "Nobody should have to choose between paying for treatment of rare diseases or feeding and schooling of their children," underlined Susanne Weissbaecker, Head Access to Medicine, GEM, Takeda.
This story is provided by NewsVoir. ANI will not be responsible in any way for the content of this article. (ANI/NewsVoir)
DISCLAIMER
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
